Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription by Swaminathan, V. et al.
MOLECULAR AND CELLULAR BIOLOGY, Sept. 2005, p. 7534–7545 Vol. 25, No. 17
0270-7306/05/$08.000 doi:10.1128/MCB.25.17.7534–7545.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Human Histone Chaperone Nucleophosmin Enhances
Acetylation-Dependent Chromatin Transcription†
V. Swaminathan, A. Hari Kishore, K. K. Febitha, and Tapas K. Kundu*
Transcription and Disease Laboratory, Molecular Biology and Genetics Unit, Jawaharlal Nehru Center
for Advanced Scientific Research, Jakkur, Bangalore 64, India
Received 1 February 2005/Returned for modification 23 February 2005/Accepted 23 May 2005
Histone chaperones are a group of proteins that aid in the dynamic chromatin organization during different
cellular processes. Here, we report that the human histone chaperone nucleophosmin interacts with the core
histones H3, H2B, and H4 but that this histone interaction is not sufficient to confer the chaperone activity.
Significantly, nucleophosmin enhances the acetylation-dependent chromatin transcription and it becomes
acetylated both in vitro and in vivo. Acetylation of nucleophosmin and the core histones was found to be
essential for the enhancement of chromatin transcription. The acetylated NPM1 not only shows an increased
affinity toward acetylated histones but also shows enhanced histone transfer ability. Presumably, nucleophos-
min disrupts the nucleosomal structure in an acetylation-dependent manner, resulting in the transcriptional
activation. These results establish nucleophosmin (NPM1) as a human histone chaperone that becomes acetyl-
ated, resulting in the enhancement of chromatin transcription.
The eukaryotic genome is packaged into a complex and
compact nucleoprotein structure, the chromatin, composed of
repeating subunits called nucleosomes. Each nucleosome is
composed of 146 bp of DNA wrapped around a proteinaceous
scaffold, which is an octamer of four core histones (H3, H4,
H2A, and H2B) (41, 64). The hallmark of chromatin is its
dynamic nature, which is necessary for the regulation of nu-
clear processes that require access to the genetic information.
Several strategies exist to alter the dynamic properties of chro-
matin, including both enzymatic and nonenzymatic methods.
Posttranslational modification of the histones and other chro-
matin-associated proteins is one such strategy (27, 66). Inter-
estingly, different modifications of the core histone tails (no-
tably, acetylation, methylation, phosphorylation, etc.) set up an
environment to facilitate chromatin dynamics in conjunction
with other remodeling systems (46, 51, 62). The role of revers-
ible acetylation in the regulation of chromatin transcription
has long been documented (3). The switching of the histone
subunit composition with conditional histone variants is an-
other strategy (reference 5 and references therein). Active
chromatin regions have been found to contain the H3.3 histone
variant, which is enriched in modifications associated with
transcriptional activity (43, 65).
Prominent among the nonenzymatic machineries that are
involved in the alteration of chromatin structure, replication-
dependent and -independent chaperones play a significant role
(40). The function of histone chaperones in chromatin repli-
cation is well established, while its involvement in other nu-
clear processes is not well documented (40, 60). Histone chap-
erones are known to be involved in chromatin reorganization
in a replication-independent manner (45). Human histone
chaperone nucleophosmin, a nucleolar protein that shuttles
between the nucleolus and nucleoplasm, shares a 50% homol-
ogy to the N terminus of the Xenopus nucleoplasmin protein
(10, 14) and possesses a unique C-terminal domain with a low
homology to known human proteins. Xenopus nucleoplasmin
has been shown to enhance transcription factor binding to
mononucleosomes (15). Though thought to play a role in ri-
bosome assembly, nucleophosmin has recently been shown to
interact with the tumor suppressor proteins p53, Rb, and ARF
(7, 16, 36, 37). Its role in stabilizing p53 is well documented (16,
37). The function of ARF is also regulated by nucleophosmin
(7). Nucleophosmin binds to several cellular and viral proteins
that include the human immunodeficiency virus Rev and Tat
proteins (20), hepatitis virus  antigen (24), and the transcrip-
tion factor YY1 (25). It is significantly abundant in tumor and
growing cells compared to normal cells (7, 14). Thus, presum-
ably, it may also play a crucial role in transcriptional regulation
in vivo.
Transcription from a chromatin template converts the pro-
moter region from a nuclease-resistant site to a nuclease-sen-
sitive one (19). This suggests that transcriptional activity results
from a deficiency of histones in the promoter region. Recent
reports have demonstrated a genome-wide loss of nucleosomes
in the regulatory region (39), suggesting that nucleosome de-
pletion could be a key step in transcriptional activation. Several
factors have been implicated in this process, though very few
have been validated. Histone hyperacetylation has been impli-
cated in this process (52), which could lead to a partial loss of
nucleosomes. The RNA polymerase II elongation complex
(FACT) is involved in the rearrangement of histones (53).
ATP-dependent remodeling factors SWI/SNF and RSC com-
plexes have been demonstrated to facilitate the removal of the
H2A-H2B dimer (11). Histone chaperones have also been
suggested to play a role in the removal of histones during
transcriptional activation. Recent evidence suggests that the
yeast antisilencing factor Asf1 assists in the removal of his-
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tones, which consequently enhances the transcriptional activity
of PHO5 and PHO8 (1, 2).
Acetylation of histones has been associated with active
genes. Further impetus to this observation came from the fact
that several transcriptional coactivators were found to possess
histone acetyltransferase (HAT) activity (56). Members of the
p300/CBP family and the GNAT family of HATs have been
shown to acetylate nonhistone proteins, which earn them the
new title of factor acetyltransferases (56, 66). Numerous tran-
scription factors are the targets of the factor acetyltransferase
activity, generally resulting in an increase in their DNA-bind-
ing ability upon acetylation (reference 4 and references
therein). Acetylation of nonhistone chromatin proteins has a
wide variety of functional consequences based on the nature
and location of these proteins in the cell. For example, acetyl-
ation of the HMGN1 and -N2 proteins by PCAF reduces its
affinity for the nucleosomes (23). Acetylation of the HMGB1
protein by CBP has been suggested to increase its affinity
toward distorted DNA and promote DNA bending (50).
In this work, we report the involvement of human nucleo-
phosmin in the regulation of acetylation-dependent chromatin
transcription. Interestingly, nucleophosmin becomes acetyl-
ated by p300, which is essential for the activation of transcrip-
tion, in conjunction with histone acetylation. The histone chap-
erone activity of nucleophosmin has been implicated in this
function. We have demonstrated that acetylation enhances the
chaperone activity with respect to core histones, while it pro-
motes nucleosomal disruption in conjunction with acetylated
core histones. This suggests that transcriptional activation in
the presence of nucleophosmin occurs through the disassembly
of nucleosomes. Thus, this report establishes nucleophosmin
as a novel human histone chaperone involved in the activation
of chromatin transcription in an acetylation-dependent man-
ner.
MATERIALS AND METHODS
Cloning of NPM1. NPM1 was subcloned between the NcoI and XhoI sites of
the pET28b vector by PCR-based subcloning from a cDNA clone. The various
deletion mutants were cloned between the NcoI and XhoI sites of the pET28b
vector by the PCR-based subcloning technique. The sense and antisense mam-
malian expression clones were cloned into the HindIII and XhoI sites of pcDNA
3.1() through PCR-based subcloning.
Purification of human core histones and recombinant proteins. Human core
histones were purified from the HeLa nuclear pellet as described earlier (35).
Acetylated core histones were purified from HeLa cells treated with 5 mM
sodium butyrate and 125 nM trichostatin A (TSA) as described above for the
core histones. The FLAG epitope-tagged PCAF was purified from the recom-
binant baculovirus-infected insect cell line Sf21 by immunoaffinity purification
using M2 agarose (Sigma) (35). Full-length p300 was also purified from the
recombinant baculovirus-infected Sf21 cells as a His6-tagged protein (34). The
His6-tagged nucleosome assembly protein 1 (NAP1) used for the in vitro chro-
matin assembly was purified from Escherichia coli cells as reported previously
(35), and the FLAG-tagged chimeric activator Gal4-VP16 was expressed in E.
coli and purified by immunoaffinity purification with M2 agarose (34). The
individual Xenopus histones were expressed and purified from E. coli cells as
described earlier (42). The His6-tagged Drosophila topoisomerase core catalytic
domain was purified as described above.
Ni-NTA pulldown assays. One microgram of the His6-tagged protein (full-
length NPM1, its deletion mutants, or acetylated NPM1) was mixed with indi-
cated amounts of the core histones, acetylated core histones, or the individual
histones in the interaction buffer (20 mM Tris-HCl [pH 7.9], 20% glycerol, 0.2
mM EDTA [pH 8.0], 0.1% Nonidet P-40, 2 mM phenylmethylsulfonyl fluoride,
300 mM KCl, 30 mM imidazole) along with the Ni-nitrilotriacetic acid (NTA)
His Bind resin (Novagen). The mixture was incubated for 2 h at 4°C on a rotary
shaker. After the beads were extensively washed in the interaction buffer, the
proteins were extracted from the beads into the sodium dodecyl sulfate (SDS)
sample buffer, separated on an SDS–12% polyacrylamide gel electrophoresis
(PAGE) gel, and either visualized by Coomassie brilliant blue (CBB) staining or
blotted and probed with appropriate antibodies.
Histone transfer assay. The nucleosome assembly activity of NPM1 and its
deletion mutants was measured as described earlier (45) with a few modifications
(see Fig. 3A). Briefly, 200 ng of closed circular G5ML (34) plasmid was relaxed
by preincubation with the Drosophila TopoI core catalytic domain in the assem-
bly buffer (34) at 37°C for 40 min. Indicated amounts of HeLa core histones or
acetylated histones and full-length NPM1, the deletion mutants, or the acetylated
NPM1 were preincubated in the assembly buffer at 37°C for 40 min. The two
reactions were mixed and incubated further at 37°C for 20 min. The reaction was
stopped by incubating at 37°C for 30 min in an equal volume of stop buffer (100
mM NaCl, 20 mM EDTA [pH 8.0], 1% SDS, 0.2 mg/ml proteinase K, 0.25 mg/ml
glycogen). Following this reaction, the plasmids were extracted using phenol-
chloroform and precipitated with ethanol. The plasmids were separated on a 1%
agarose gel and visualized by staining with ethidium bromide. For the dose-
dependent assays with acetylated NPM1, the postrelaxation incubation was re-
duced to 10 min to perceive the difference in the histone transfer compared to
the unacetylated NPM1.
In vitro chromatin assembly. A chromatin template for in vitro transcription
experiments was assembled and characterized as described earlier (34).
In vitro transcription assay. Transcription assays were essentially carried out
as described elsewhere (34) with minor modifications. The scheme of transcrip-
tion is enumerated in Fig. 3A. Briefly, 28 ng of DNA or an equivalent amount of
chromatin template was incubated with 30 ng of activator (Gal4-VP16) in a
buffer containing 4 mM HEPES (pH 7.8), 20 mM KCl, 2 mM dithiothreitol, 0.2
mM phenylmethylsulfonyl fluoride, 10 mM sodium butyrate, 0.1 mg/ml bovine
serum albumin, and 2% glycerol (35). Twenty nanograms of p300 and 1.5 M
acetyl coenzyme A (acetyl-CoA) was added and the reaction incubated at 30°C
for 15 min. Indicated amounts of NPM1 or its deletion mutants were added to
the reaction, which was incubated at 30°C for 30 min. HeLa nuclear extract (NE;
5 l, which contains 8 mg/ml protein) was added to initiate the preinitiation
complex formation. Transcription reaction was started by the addition of NTP
mix (12 mM concentrations of ATP and CTP, 0.5 mM UTP, 2 mM 3 O-methyl
GTP) and [-32P]UTP after the preinitiation complex formation. The incubation
was continued for 40 min at 30°C. Transcription was terminated by the addition
of 250 l of stop buffer (20 mM Tris-HCl [pH 8.0], 1 mM EDTA, 100 mM NaCl,
1% SDS, 0.025 ng/l tRNA). The 32P-radiolabeled transcript was extracted with
phenol-chloroform, ethanol precipitated, and dried and the pellet dissolved in
loading dye (8 M urea, 0.005% bromphenol blue, and xylene cyanol in 1
Tris-borate-EDTA [TBE]) and analyzed on a urea–5% polyacrylamide gel. Gels
were then dried and subjected to autoradiography at 70°C. Quantification of
transcription was done by using the Fuji BAS system and analyzed by using
ImageQuant software. Quantitation of DNA and chromatin transcription data
represent three independent experiments. In the case of interrupted transcrip-
tion experiments, 10 nM lysyl-CoA, a p300 HAT-specific inhibitor, was added
immediately after the acetylation reaction and the reaction was incubated for 15
min at 30°C. The rest of the reaction was carried out as described above.
In vitro acetylation assay and mass acetylation. In vitro acetylation assays
were performed as described elsewhere (33). Indicated amounts of proteins (see
figure legends) were incubated at 30°C for 30 min in a 30-l final reaction volume
consisting of 50 mM Tris-HCl (pH 8.0), 10% (vol/vol) glycerol, 1 mM dithio-
threitol, 1 mM phenylmethylsulfonyl fluoride, 0.1 mM EDTA (pH 8.0), 10 mM
sodium butyrate, and 0.5 l of 3.3 Ci/mmol [3H]acetyl-CoA. The reaction mix-
ture was then blotted onto P-81 filter paper. Radioactive counts were recorded
on a Wallac 1409 liquid scintillation counter. To visualize the radiolabeled
acetylated protein, the reaction products were precipitated with 25% trichloro-
acetic acid, washed with ice-cold acetone, and resolved electrophoretically on an
SDS–15% polyacrylamide gel and subjected to fluorography using a solution
containing 22.5% 2,5-diphenyloxazole in Me2SO (9). Gels were dried, and au-
toradiography was performed at 70°C for 1 to 2 days. For the mass acetylation
reaction, 12 g of NPM1 and 100 ng full-length p300 were incubated in the
presence of 50 M acetyl-CoA at 37°C for 1.5 h. To achieve efficient acetylation,
p300 and acetyl-CoA were added at every 30-min interval.
MALDI analysis of acetylated nucleophosmin. Mass-acetylated protein was
separated on an SDS–12% PAGE gel, the band excised out, and in-gel protease
digestion carried out in ammonium bicarbonate buffer as described elsewhere
(54). The different proteases used were trypsin, Asp-N, and Glu-C (Sigma). The
resultant peptides were extracted in 50% acetonitrile–5% formic acid and the
peptide masses analyzed on a Bruker Daltonics matrix-assisted laser desorption
ionization–time of flight (MALDI-TOF) machine.
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Luciferase assay. 293T cells were maintained at 37°C with 5% CO2 in Dul-
becco’s modified Eagle medium with 10% fetal bovine serum. The mammalian
expression constructs of p53, Gal4-VP16, and NPM1 sense and antisense con-
structs used in this study were placed under a cytomegalovirus (CMV) promoter.
The p53-responsive reporter construct pG13luc contains 13 consensus p53-bind-
ing sites in tandem followed by a polyomavirus promoter, which drives the
luciferase gene (28). The Gal4-VP16-responsive reporter construct pG10luc con-
tains 10 Gal4-binding sites in tandem followed by the luciferase gene. These
reporter constructs were used to probe into the effect of NPM1 overexpression
on the p53- and Gal4-VP16-mediated gene expression in vivo. The CMV-driven
	-galactosidase (pCMV-	gal) construct was used as an internal control. Prior to
transfection, cells were seeded at 0.6  106 cells per 60-mm-diameter dish and
transfected with the different plasmid constructs by using Lipofectamine 2000
Plus (Invitrogen) according to the manufacturer’s protocol. An empty vector was
used to keep the total amount of DNA constant in each transfection. Luciferase
and 	-galactosidase activities were measured 48 h after the transfection by
luciferase assay and 	-galactosidase assay systems according to the procedure
provided by the manufacturer (Promega). The transient transfection assay was
performed three times independently to monitor average relative luciferase
activity.
In vivo acetylation status of nucleophosmin. 293T cells were treated with 5
mM sodium butyrate, 100 nM trichostatin A, and 1 mCi/ml [3H]sodium acetate
for a period of 24 h, following which the cell lysate was prepared in radioimmu-
noprecipitation assay buffer and nucleophosmin was immunoprecipitated with
the monoclonal antibody against NPM1 (Sigma). The immune complex was
separated on an SDS–12% PAGE gel and subjected to fluorography as described
above. Gels were dried, and autoradiography was performed at 70°C for 1 to
2 days. In a separate experiment, the pulldown complexes were separated on an
SDS–12% PAGE gel, blotted onto a nitrocellulose membrane, and probed with
antibody against acetylated lysine (Calbiochem).
Acetylation of NPM1 under transcription conditions. In vitro transcription
reactions were carried out on a chromatin template in the presence of [3H]acetyl-
CoA as described in Fig. 5A and terminated following the remodeling step. The
samples were precipitated using trichloroacetic acid to a final concentration of
25% and separated on an SDS–12% PAGE gel. The gel was then subjected to
fluorography as described above. Gels were dried, and autoradiography was
performed at 70°C for 2 to 4 days.
RESULTS
In vitro binding preference of nucleophosmin to core his-
tones. Histone chaperones are a class of histone-interacting
proteins that aid in a wide variety of processes that involve
chromatin (40). This class of proteins has been postulated to
possess the ability to alter local chromatin structure and facil-
itate nuclear processes that include transcription. In a classical
report, it was shown that a Xenopus histone chaperone nucleo-
plasmin enhances transcription factor binding to mononucleo-
somes by displacing the nucleosomal histones (15). Human
nucleophosmin/B23 (NPM1) shows 50% similarity with the
N-terminal region of Xenopus nucleoplasmin (14, 18), which
has been demonstrated to interact with the histone pair H2A-
H2B (6). We investigated the histone interaction pattern for
nucleophosmin. We cloned, expressed, and purified full-length
His6-tagged nucleophosmin from E. coli. The authenticity of
the recombinant protein was confirmed using the NPM1
monoclonal antibody (see the supplemental material) and
mass spectrometric analysis.
We used the Ni-NTA pulldown assay to map the interaction
profile of nucleophosmin with the core histones. Highly puri-
fied human core histones from HeLa cells (see the supplemental
material) were incubated along with the recombinant His6-
tagged nucleophosmin and the Ni-NTA beads in the interac-
tion buffer containing 300 mM salt (see Materials and Meth-
ods). Full-length nucleophosmin could pull down all four core
histones, while the beads alone did not pull down any protein
(Fig. 1B, top panel, lane 3 versus lane 2). We also carried out
immunoblots on the pulldown product with antibodies against
the core histones, which validated the earlier statement (Fig.
1B, Western blot, lane 3 versus lane 2). Most histone chaper-
ones have been documented to possess a preferential affinity
toward either the H3-H4 tetramer or the H2A-H2B dimer (40,
61). Our data suggest that nucleophosmin interacts either with
all the core histones or at least with one partner each in the
H3-H4 tetramer or H2A-H2B dimer. We repeated the inter-
action of nucleophosmin with recombinant individual histones
from Xenopus (42) and probed the blot with antibodies raised
against H3, H2A, and H2B. Interestingly, nucleophosmin
strongly interacted with H3, H4, and H2B, while it did not
interact with H2A (Fig. 1C, lanes 1). None of the individual
histones were pulled down by using Ni-NTA beads alone (Fig.
1C, lanes 5). These results indicate that H2A in HeLa core
histones is pulled down by nucleophosmin as a dimer, along
with H2B.
Nucleophosmin has a modular structure, with a hydrophobic
N terminus, important for oligomerization; two acidic stretches
separated by the bipartite nuclear localization signal; and a
unique C-terminal domain (Fig. 1A). We wanted to map the
precise region of NPM1 that interacts with the histones. We
subcloned different His6-tagged C-terminal truncations of
NPM1 (Fig. 1A) that sequentially eliminated the unique C-
terminal domain (NPM1 1-200), the second acidic stretch and
nuclear localization signal (NPM1 1-147), and finally, the first
acidic stretch (NPM1 1-119), leaving the oligomerization do-
main intact. These deletion mutants were expressed and puri-
fied from E. coli (see the supplemental material). We then
used the Ni-NTA pulldown assay to test the histone-interacting
ability of the deletion mutants. The mutants NPM1 1-200 and
1-147 could interact with both core histones (Fig. 1B, lanes 4
and 5 versus lanes 3) and the individual recombinant histones
(Fig. 1C, lanes 2 and 3 versus lanes 1) to the same extent as the
full-length protein. However, the N-terminal oligomerization
domain (NPM1 1-119) interacted very feebly with the H3-H4
tetramer (Fig. 1B, lanes 6 versus lanes 3), while in the case of
the individual histones, the binding of histone H2B was com-
pletely abolished (Fig. 1C, second panel, lane 4 versus lanes 1
through 3). Histones H3 and H4 could still interact, albeit with
less efficiency (Fig. 1C, lanes 4 versus lanes 1 through 3). These
results are in contrast to those in an earlier report wherein
nucleophosmin was suggested to possess a preference for his-
tone H3 (48). In our report, we have shown that human nu-
cleophosmin interacts with both the histone tetramer and the
dimer, despite a lack of interaction with histone H2A. Most
histone chaperones do not require the acidic stretch for the
histone interaction (20, 58). Taken together, these data show
that nucleophosmin can interact with the H3-H4 tetramer
through the N terminus and the H2B-H2A dimer through the
first acidic stretch.
Histone transfer activity of nucleophosmin. The ability of
nucleophosmin to assemble nucleosomes on a plasmid was
tested as a measure of its function as a histone chaperone. The
plasmid supercoiling assay (Fig. 2A) measures the assembly
activity on the basis of the introduction of negative supercoils
on a relaxed template (47). The full-length nucleophosmin
could introduce negative supercoils on the plasmid DNA in the
presence of TopoI and core histones (Fig. 2B, lane 4). In order
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to map the chaperone domain and to correlate it with the
histone interaction ability of nucleophosmin, we tested the
different deletion mutants for their assembly activity. Interest-
ingly, we found that the chaperone activity of nucleophosmin
dropped by 40% upon the deletion of 94 C-terminal amino
acids (NPM1 1-200) (Fig. 2B, lane 6 versus lane 4) and by 70%
upon the deletion of 147 C-terminal amino acids (NPM1
1-147), compared to the full-length nucleophosmin (Fig. 2B,
lane 8 versus lane 4). Interestingly, the N-terminal oligomer-
ization domain did not show any histone transfer activity (Fig.
2B, lane 10 versus lane 4). These two activities of nucleophos-
min were compared by quantifying the percentage of histone
H3 bound as well as the percentage of supercoiled DNA
formed in each case. A gradual loss of chaperone activity was
noted upon the sequential deletion of the C-terminal domain,
while the ability to interact with the core histones remained
intact for all mutants except the N-terminal oligomerization
domain (Fig. 2C). This suggested that the histone-binding abil-
ity of nucleophosmin is functionally separate from the chaper-
one activity. Interestingly, the histone-binding region is at the
N terminus while the chaperone activity is at the C terminus,
suggesting a distinct modular nature of the nucleophosmin
protein. These results indicate that the histone interaction
ability of human nucleophosmin is necessary but not sufficient
for its histone transfer ability.
Nucleophosmin stimulates acetylation-dependent chroma-
tin transcription. Based on its ability to interact with and
transfer the histones, we investigated the role of nucleophos-
min in transcriptional regulation. For this purpose, the in vitro
transcription assay based on a nucleosomal array template was
used with necessary modifications. The chromatin template
was assembled on a previously relaxed pG5ML array plasmid
(34) by incubating it with HeLa core histones and recombinant
mouse NAP1. The assembly of chromatin was confirmed using
the supercoiling and partial MNase digestion assays.
Transcription assays followed the protocol represented in
Fig. 3A. The different steps include activator binding, histone
acetylation by p300 and acetyl-CoA, incubation with nucleo-
phosmin, preinitiation complex assembly, and the final tran-
scription step. HeLa NE was used as a source of the general
transcription factors and cofactors. Nucleophosmin is an abun-
dant protein in the nucleus of HeLa cells. In order to under-
stand the exact role of nucleophosmin in transcription, we
immunodepleted nucleophosmin from NE (see the supple-
mental material). The nucleophosmin-depleted NE was found
to be equally efficient as undepleted NE, as characterized by
activator-dependent transcription from a DNA template (see
the supplemental material). Interestingly, the exogenous addi-
tion of nucleophosmin did not affect the transcription from the
DNA template (see the supplemental material).
FIG. 1. Nucleophosmin interacts with the core histones preferentially. (A) Schematic representation of the C-terminal deletion mutants of
nucleophosmin with the key to domain organization. (B and C) Interaction of the His6-tagged, full-length (FL) nucleophosmin and its deletion
mutants (1 g) with HeLa core histones (5 g) (B) or individual recombinant histones (C) was investigated using a Ni-NTA pulldown assay. The
beads were loaded on an SDS–12% PAGE gel and visualized by CBB staining. The same was blotted on a polyvinylidene difluoride membrane
and probed with antibodies against different histones as indicated.
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Addition of nucleophosmin to the chromatin transcription
reaction in the absence of acetylation (without the addition of
p300 and acetyl-CoA), up to 50 pmol, could not activate tran-
scription (see the supplemental material). In agreement with
previously published results (34), a 10-fold transcriptional ac-
tivation was observed upon the addition of p300 and acetyl-
CoA (see the supplemental material), confirming the tran-
scriptional competence of the system. However, the ectopic
addition of nucleophosmin in a dose-dependent manner up to
50 pmol into the acetylation-dependent chromatin transcrip-
tion system showed a further 4-fold increase over the acety-
lated chromatin lane (Fig. 3B, lane 8 versus lane 4). We also
tested the ability of the different deletion mutants for activat-
ing chromatin transcription. Two different concentrations of
each deletion mutant (5 and 50 pmol) were tested out. NPM1
1-200 and 1-147 showed a marginal activation at 50 pmol (Fig.
3C, lanes 8 and 10 versus lane 6), while the NPM1 1-119
mutant showed no enhancement in chromatin transcription
(Fig. 3C, lanes 11 and 12 versus lane 4). These results hint at
a correlation between transcriptional activation and the his-
tone transfer activity of nucleophosmin and not a dependence
on its histone-interacting ability alone. Most significantly, nu-
cleophosmin could enhance the transcription from the chro-
matin template only when p300 and acetyl-CoA were present.
Nucleophosmin becomes acetylated both in vitro and in
vivo. The absolute dependence of nucleophosmin on the acet-
ylation step for the transcriptional activation tempted us to
investigate whether NPM1 itself becomes acetylated by p300.
We carried out an in vitro acetylation assay (see Materials and
Methods) using p300 and PCAF as histone acetyltransferases
and [3H]acetyl-CoA. The activities of both acetyltransferases
were normalized using histones as substrate (data not shown).
The normalized acetyltransferases were then assayed for their
ability to acetylate nucleophosmin. Interestingly, it was found
that nucleophosmin becomes acetylated specifically by p300
and not by PCAF (Fig. 4A, lanes 4 versus lanes 6). p300 has a
specificity to acetylate histones H3 and H4 in vitro and all core
histones in vivo, apart from a range of nonhistone substrates
which include the transcriptional coactivator PC4 (33), p53
(22), different high-mobility group proteins (12, 23), and hu-
man immunodeficiency virus Tat (29), among others. Notably,
this is the first report on the acetylation of a histone chaperone.
We went on to map the exact acetylation sites on nucleo-
phosmin by subjecting the in vitro-acetylated protein to
MALDI-TOF analysis following its protease digestion. Inter-
estingly, most acetylation sites were found to lie in the C-
terminal domain of nucleophosmin. Though five acetylation
FIG. 2. The histone chaperone activity of nucleophosmin is independent of its histone interaction. (A) Schematic depiction of the histone
transfer assay to test the histone chaperone function of NPM1. (B) Histone transfer assay was carried out with 500 ng of histones and 250 ng of
either full-length (FL) NPM1 or the deletion mutants. Lane 1, supercoiled DNA; lane 2, DNA relaxed by TopoI; lane 3, relaxed DNA with core
histones; lane 4, relaxed DNA with core histones and full-length NPM1. Relaxed DNA without (lane 5) or with (lane 6) core histones and NPM1
1-200, relaxed DNA without (lane 7) or with (lane 8) core histones and NPM1 1-147, and relaxed DNA without (lane 9) or with (lane 10) core
histones and NPM1 1-119 are shown. (C) Comparative analysis of the amount of supercoiled DNA and the histone H3-binding ability of NPM1
FL or each of the deletion mutants. The supercoiled DNA formed was quantified using Image Gauge software (Fuji) and expressed as a percentage
of the total supercoiled DNA used. The percentage of histone H3 binding was calculated similarly.
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sites could be assigned confirmedly, there are a few more sites
that are yet to be annotated (Fig. 4D and Table 1).
To ensure the acetylation of nucleophosmin in vivo, it was
immunoprecipitated from 293T cells that were previously
treated with histone deacetylase inhibitors and [3H]sodium
acetate. The immunoprecipitated protein was separated by
SDS-PAGE and the label detected by fluorography (Fig. 4B,
lane 2). As a control for the nonspecific pulldown, we used
anti-mouse immunoglobulin G with the treated lysate (Fig. 4B,
lane 1). These results showed that indeed nucleophosmin be-
comes acetylated in vivo. In order to confirm that NPM1 was
acetylated under normal growth conditions, unlike under
growth-restrictive conditions in the presence of TSA, we re-
peated the experiment in the presence and absence of TSA-
NaBu. Interestingly, we found that the NPM1 was acetylated
under normal and growth-restrictive conditions (Fig. 4C, top
panel). As reported earlier, we also noted that there was a drop
in the levels of the NPM1 protein itself upon treatment with
TSA (Fig. 4C, bottom panel) (13). Taken together, these re-
sults confirm that a substantial population of NPM1 is present
in the acetylated form under normal growth conditions.
Acetylation of NPM1 is essential for the stimulation of chro-
matin transcription. Nucleophosmin stimulates acetylation-
dependent chromatin transcription and itself becomes acety-
lated. Based on these two observations, we wanted to dissect
out the requirement of nucleophosmin acetylation on its ability
to activate chromatin transcription. In order to address this
question, the scheme of transcription was modified as depicted
in Fig. 5A. In order to differentiate between the effect of
acetylated and unacetylated nucleophosmin on chromatin
transcription, the acetylation step was interrupted with the
help of the p300-specific HAT inhibitor lysyl-CoA (38). This
ensures that the exogenously added unacetylated nucleophos-
min, added after the acetylation step, does not become acetyl-
ated by the p300 HAT. The transcription reaction was carried
out without the addition of lysyl-CoA as a control. Since the
reaction was subjected to a longer time point, without the
addition of lysyl-CoA, the difference in transcriptional activa-
tion dropped 1.8- to 2-fold (Fig. 5B, lanes 5 and 6 versus lane
4) compared to 2.5-fold in the earlier experiment (Fig. 3B).
Interrupted acetylation impairs chromatin transcription,
producing 10-fold reduction compared to the uninterrupted
FIG. 3. Nucleophosmin stimulates acetylation-dependent chromatin transcription. (A) Schematic representation of the in vitro transcription
protocol. RT, room temperature; PIC, preinitiation complex. (B) Freshly assembled chromatin (28 ng) was subjected to the protocol described for
panel A. NPM1 stimulates chromatin transcription in a dose-dependent manner. Lane 1, without activator; lanes 2 through 8, with Gal4-VP16 (50
ng); lanes 3 through 8, with p300 (25 ng); lanes 4 through 8, with acetyl-CoA (ACoA; 1.5 M); lanes 5 through 8, 1, 10, 30, and 50 pmol of
full-length NPM1, respectively. (C) Freshly assembled chromatin (28 ng) was subjected to the protocol described for panel A. Lane 1, without
activator; lanes 2 through 12, with Gal4-VP16 (50 ng); lanes 3 through 12, with p300 (25 ng); lanes 4 through 12, with acetyl-CoA (1.5 M). Lanes
5, 7, 9, and 11, have 5 pmol and lanes 6, 8, 10, and 12 have 30 pmol of full-length (FL) NPM1 or the respective deletion mutants added as indicated.
The relative transcription per lane (in severalfold activation over the acetylation-dependent transcription lane [lane 4]) was determined by
phosphorimage analysis (Fuji) and presented under each lane along with the standard deviation. n.d., not determined.
VOL. 25, 2005 NUCLEOPHOSMIN ENHANCES CHROMATIN TRANSCRIPTION 7539
reaction (Fig. 5B, lane 7 versus lane 4). Exogenous addition of
nucleophosmin to this reaction produced a modest increase in
the transcript levels (Fig. 5B, lane 8 versus lane 7). Interest-
ingly, the addition of preacetylated nucleophosmin to the in-
terrupted acetylation reaction produced a 5-fold increase in
the transcript levels (Fig. 5B, lane 9 versus lane 8). These data
suggest that the acetylation of nucleophosmin is an essential
requirement in the activation of transcription from the chro-
matin template.
In order to further clarify whether the acetylation of nucleo-
phosmin alone is sufficient for transcriptional activation, we
carried out an acetylation-independent transcription experi-
ment with the exogenous addition of unacetylated and acetyl-
ated nucleophosmin. The absence of the characteristic activa-
tion in either case (Fig. 5B, lanes 10 and 11 versus lane 2)
argues for the fact that acetylation of the chromatin template
is a necessary prerequisite for the transcriptional enhancement
brought about by acetylated nucleophosmin.
FIG. 4. Nucleophosmin becomes acetylated both in vitro and in vivo. (A) In vitro gel HAT assay carried out with NPM1 as a substrate without
(lanes 1 and 2) or with (lanes 3 and 4) the activity-normalized p300. The acetylation reactions were also tested with PCAF (lanes 5 and 6) as the
histone acetyltransferases. Lanes 2, 4, and 6 show the acetylation reaction in the presence and lanes 1, 3, and 5 in the absence of [3H]acetyl-CoA.
The gel was then subjected to CBB staining and fluorography and exposed to an X-ray film. Top panel shows the CBB-stained gel, while the bottom
panel shows the autoradiogram. (B) In vivo acetylation of nucleophosmin. Nucleophosmin was immunoprecipitated with the monoclonal antibody
(lane 2) from 293T cells treated with deacetylase inhibitors (500 ng/ml TSA and 5 mM sodium butyrate) as well as [3H]sodium acetate. The
immunoprecipitate was analyzed on an SDS–12% PAGE gel and processed as described for panel A. Mouse preimmune serum was used as an
immunoprecipitation control (lane 1). IgG, immunoglobulin G. (C) In vivo acetylation of nucleophosmin under normal growth conditions.
Nucleophosmin was immunoprecipitated (IP) with the monoclonal antibody from 293T cells treated with deacetylase inhibitors (500 ng/ml TSA
and 5 mM sodium butyrate). The immunoprecipitate was analyzed on an SDS–12% PAGE gel, blotted, and probed with antibody against
acetylated lysine (panel I). The lysates used in the pulldown assay were analyzed on an SDS–12% PAGE gel, blotted, and probed with the antibody
against NPM1 (panel II). (D) Protein sequence of nucleophosmin showing the acetylation sites. The lysine residues are shaded. The lysines that
are acetylated are marked “Ac,” while the ones that are not acetylated are marked with a bullet. Lysines that could not be assigned as either of
the above have been left unmarked.
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In order to ensure that the addition of lysyl-CoA indeed
inhibits the HAT activity of p300, we carried out the transcrip-
tion reaction in the presence of [3H]acetyl-CoA and analyzed
the reaction for the acetylation status of NPM1. The data
clearly indicate that NPM1 acetylation is substantially reduced
in the presence of lysyl-CoA (Fig. 5C, lanes 3 versus lanes 2).
These results clearly establish the fact that acetylation of
NPM1 is essential for the enhancement of acetylation-depen-
dent chromatin transcription.
p300-mediated acetylation of nucleophosmin and histones
leads to chromatin disassembly. We have shown that the nu-
cleophosmin-mediated activation of chromatin transcription
also requires the acetylation of the histone chaperone. In order
to investigate the functional attributes conferred on nucleo-
phosmin upon acetylation by p300, the histone interaction pro-
file of the modified protein was probed into. Since transcrip-
tional activation from a chromatin template requires the
acetylation of histones, the interaction of both acetylated and
unacetylated nucleophosmins with increasing amounts of hu-
man hyperacetylated histones (see Materials and Methods)
was also investigated using the Ni-NTA pulldown method.
Though unacetylated or acetylated nucleophosmin did not
show any preference for unacetylated histones (Fig. 6A, lanes
6, 7, and 8 versus lanes 3, 4, and 5, respectively), acetylated
nucleophosmin showed a marked preference for acetylated
histones (Fig. 6B, lanes 8 versus lanes 5). Quantification of
these data using ImageQuant software (Fuji Films) revealed a
threefold increase in the pulldown of acetylated histones by
FIG. 5. Acetylation of nucleophosmin is critical for transcriptional activation from a chromatin template. (A) Schematic representation of in
vitro transcription protocol modified to include the interrupted acetylation step (addition of the p300-specific inhibitor lysyl-CoA). RT, room
temperature; PIC, preiniation complex. (B) Freshly assembled chromatin (28 ng) was subjected to the protocol described for panel A without or
with Gal4-VP16, full-length p300, or 1.5 M acetyl-CoA (ACoA) and without or with the p300-specific HAT inhibitor lysyl-CoA, along with 30
pmol (each) of full-length NPM1 or acetylated NPM1 as indicated. The relative transcription per lane (in severalfold activation over the respective
control lanes marked with the number 1) was determined by phosphorimage analysis (Fuji) and presented under each lane along with the standard
deviation, calculated from three independent experiments. (C) Acetylation status of NPM1 under the transcription conditions. Chromatin was
subjected to the transcription protocol enumerated for panel A in the presence of [3H]acetyl-CoA, terminating the reaction after the remodeling
step with (lane 2) or without (lane 3) lysyl-CoA, in the presence (lanes 2 and 3) or absence (lane 1) of NPM1. The top panel shows the Coomassie
blue-stained gel, while the bottom panel shows the autoradiogram.
TABLE 1. Acetylation sites on nucleophosmin
Mass (Da) Sequence
Sequence Protease
Observed Unmodified 
 Start End
1,276.7755 1,234.4529 42.3226 246 256 DIKAKMQSIE Glu-C
1,274.4924 1,232.4270 42.0654 286 294 DLWQWRKSL Asp-N
851.2379 766.8719 84.3660 227 232 SFKKQE Glu-C
848.9597 806.4076 42.5521 251 257 MQASIEK Trypsin
689.3119 647.3107 42.0012 207 212 SNQNGK Trypsin
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acetylated nucleophosmin. These results indicate an increased
affinity for acetylated histones upon the acetylation of nucleo-
phosmin. This also raises the possibility that acetylated nucleo-
phosmin may facilitate the removal of acetylated histones from
the chromatin.
We then checked the chaperone activity of unacetylated and
acetylated nucleophosmin with HeLa core histones and HeLa
hyperacetylated histones. The unacetylated nucleophosmin
showed no alteration in its ability to transfer acetylated his-
tones onto the DNA template compared to the unacetylated
histones (data not shown). Surprisingly, acetylated nucleo-
phosmin showed an increased chaperone activity with unacet-
ylated core histones in a dose-dependent manner (Fig. 6C,
lanes 6 through 11) while it demonstrated a reduced ability to
transfer acetylated histones, as supported by the prevalence of
intermediate forms (data not shown). These data suggest that
the transcriptional activation of a chromatin template by nu-
cleophosmin requires the acetylation of both the histone and
the histone chaperone, presumably leading to the depletion of
the acetylated histones.
Nucleophosmin acts as a transcriptional enhancer in vivo.
We have established the fact that nucleophosmin can indeed
activate HAT-dependent chromatin transcription by the dis-
ruption of the nucleosomes in an in vitro system. To validate
these results in the cellular environment, we proceeded to
clone nucleophosmin into a mammalian expression vector
[pcDNA 3.1()]. Nucleophosmin was cloned in both the sense
and antisense directions to achieve the overexpression and
silencing of nucleophosmin expression, respectively. These
FIG. 6. Acetylation of nucleophosmin and core histones potenti-
ates their interaction and nucleosome disruption. (A) Effect of acet-
ylation on NPM1 and histone interaction. Indicated amounts of nor-
mal (untreated) core histones purified from the HeLa nuclear pellet
were tested for their interaction with 1 g of either NPM1 (lanes 3, 4,
and 5) or acetylated NPM1 (lanes 6, 7, and 8) using the Ni-NTA
pulldown assay. Ni-NTA beads alone, without NPM1 or acetylated
NPM1, were used as a negative control (lane 2). Four micrograms of
the sample was loaded as input (lane 1). The top panel is the Coo-
massie blue-stained gel showing the amounts of the pulled-down pro-
teins, while the bottom panel shows the Western immunoblot (IB) with
antihistone H3. (B) Effect of acetylation on NPM1 and acetylated
histone interaction. Indicated amounts of hyperacetylated core his-
tones purified from the HeLa nuclear pellet were tested for their
interaction with 500 ng of either NPM1 (lanes 3, 4, and 5) or acetylated
NPM1 (lanes 6, 7, and 8) using the Ni-NTA pulldown assay. Ni-NTA
beads alone, without NPM1 or acetylated NPM1, were used as a
negative control (lane 2). Two micrograms of the sample was loaded as
input (lane 1). The top panel is the Coomassie blue-stained gel show-
ing the amounts of the pulled-down proteins, while the bottom panel
shows the Western blot with antibodies against acetylated histone H3.
(C) Acetylated NPM1 transfers histones more efficiently than NPM1.
Histone transfer was tested with 500 ng of core histones and increasing
concentrations of either NPM1 (lanes 6, 8, and 10) or the acetylated
NPM1 (lanes 7, 9, and 11). Lane 1, supercoiled DNA; lane 2, DNA
relaxed by TopoI; lanes 3 through 11, relaxed DNA along with core
histones (lane 3), NPM1 (lane 4), or acetylated NPM1 alone (lane 5)
and 0.5, 1, or 5 pmol (lanes 6 and 7, 8 and 9, and 10 and 11, respec-
tively) of either NPM1 and acetylated NPM1, respectively.
FIG. 7. Nucleophosmin induces p53-mediated transcription in
vivo. (A) The lysates used in the luciferase assays [NPM1 () (lane 1),
vector-transfected control (VC) (lane 2), NPM1 () (lane 3)] were
separated on an SDS–12% PAGE gel and immunoblotted with anti-
NPM1 or anti-actin as indicated. (B and C) 293T cells were transiently
transfected either with 1 g of pG13luc (B) or pG10luc (C), 250 ng of
pIRES puro-p53 (B) or Gal4-VP16 (C), or 1 g of pCMV-	gal and
with 2 g of either pcDNA3.1, pcDNA3.1 NPM1 (), or pcDNA3.1
NPM1 (). The p53-driven luciferase activity was measured and nor-
malized with the beta-galactosidase activity. The severalfold increase
or decrease in the luciferase activity over the VC (bar 2) in the case of
NPM1 () (bar 1) and NPM1 () (bar 3) has been presented as a bar
diagram.
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mammalian expression clones were transfected into the 293T
cells and checked for their ability to alter the expression of
nucleophosmin. The sense clone NPM1 () could overexpress
up to four times more (Fig. 7A, lanes 1 versus lanes 2), while
the antisense clone NPM1 () abolished the expression of
nucleophosmin by 80% (Fig. 7A, lanes 3 versus lanes 2) as
revealed by Western blot analysis on the lysates of transfected
cells.
We used the p53-responsive synthetic reporter gene
pG13luc, which contains 13 p53-binding sites upstream of the
luciferase gene construct (28), to test the effect of nucleophos-
min coexpression. The p53-responsive pG13luc vector was co-
transfected along with the mammalian expression vector for
p53 and either one of the nucleophosmin sense, antisense, or
parental vector clones. The 	-galactosidase gene under the
CMV promoter was cotransfected for internal control. The
normalized reporter gene expression was plotted as the in-
crease or decrease over the parental vector control. Concom-
itant with our chromatin transcription data, we found that
overexpression of nucleophosmin produces a fourfold increase
in reporter gene expression (Fig. 7B, bar 1 versus bar 2), while
silencing the nucleophosmin expression reduces the transacti-
vation 1.5-fold (Fig. 7B, bar 3 versus bar 2). Interestingly, it
also suggests that the histone chaperone nucleophosmin could
be an important determinant for the p53-mediated gene ex-
pression.
NPM1 and p53 are known to interact with each other (16,
37), resulting in a functional modulation of p53. In order to test
the global effect of NPM1 overexpression, we repeated the
reporter assay using a different transactivator, Gal4-VP16, and
a Gal4-responsive luciferase cassette. Interestingly, cotransfec-
tion of Gal4-VP16 and NPM1 () resulted in a 30-fold in-
crease in the reporter gene expression (Fig. 7C, bar 1 versus
bar 2), while knockdown of the NPM1 gene expression did not
produce any change in the reporter gene expression (Fig. 7C,
bar 3 versus bar 2). These results clearly demonstrate that the
histone chaperone nucleophosmin induces transcription glo-
bally in vivo, probably through the disruption of the chromatin
template.
DISCUSSION
The regulation of chromatin transcription is a complex phe-
nomenon that involves the sequential remodeling of chromatin
followed by the recruitment of the general transcription ma-
chinery to a targeted promoter (17, 35, 59). The critical event
in this sequence is the remodeling step that results in a greater
accessibility of chromatin, thereby promoting the formation of
the preinitiation complex. A large number of factors that re-
model chromatin have been defined. The common target for
all these factors is the histones, which are either posttransla-
tionally modified (acetylation, phosphorylation, methylation,
etc.) (27, 32, 51) or rearranged or disrupted by a host of
energy-dependent remodeling factors (30, 62). In this report,
we introduce a member of the human histone chaperone fam-
ily, nucleophosmin, as a novel chromatin-remodeling factor
which is involved in the activation of chromatin transcription.
Furthermore, we also report that this histone chaperone is
functionally regulated by its acetylation, a posttranslational
modification first reported in the case of histone chaperones.
Nucleophosmin, like other histone chaperones, is capable of
interacting with the core histones. It interacts with both the
H3-H4 tetramer and the H2A-H2B dimer concomitantly, re-
sulting in the pulldown of the histone octamer. This is possible
due to the fact that these two subspecies of the octamer bind to
separate domains of nucleophosmin, as demonstrated in this
report. A similar model has been proposed for Xenopus
nucleoplasmin (6). Another interesting feature of the interac-
tion map is that nucleophosmin does not interact with histone
H2A, while it interacts with H3, H4, and H2B (Fig. 1C). It is on
the basis of its interaction with H2B that nucleophosmin pulls
down H2A from core histones (Fig. 1B). Domainwise mapping
of the histone-interacting region reveals that the N-terminal
hydrophobic oligomerization domain is responsible for binding
to the H3-H4 tetramer, while the first acidic stretch is neces-
sary for binding to H2B. This is similar to what has been
observed in the case of the Saccharomyces cerevisiae Asf1 pro-
tein, wherein the acidic stretch has been shown to interact with
H2A-H2B (58). But unlike nucleophosmin, this property was
observed only when the N-terminal region of Asf1 was deleted.
Most histone chaperones show a preference for either the
H3-H4 tetramer (CAF1) (61) or the H2A-H2B dimer (NAP1)
(references 21, 26, and 49 and references therein), but we
could not detect any preference for either subspecies for nu-
cleophosmin.
The C-terminal domain of nucleophosmin is unique and
possesses the histone chaperone activity. It is interesting to
note that the two related activities of histone interaction and
histone transfer ability (histone chaperone) are located at op-
posing ends of the protein. Indeed, C-terminal truncations of
nucleophosmin abrogate the chaperone activity while the his-
tone interaction remains intact. It has been reported earlier
that the C terminus of nucleophosmin possesses the nucleic
acid-binding site (63). This observation leads to the speculation
that nucleic acid binding could facilitate histone assembly. It is
interesting to note that the existence of a nucleic acid-binding
domain is not documented for other histone chaperones.
We have shown in this report that the human histone chap-
erone nucleophosmin can activate transcription from a chro-
matin template. Exogenous addition of nucleophosmin does
not affect DNA transcription, suggesting that nucleophosmin
targets the chromatin and not the general transcription factors
for its action. This study employed a highly purified nonenzy-
matic chromatin assembly system in conjunction with an array
template (34). With this system, we avoided the usage of other
chromatin-remodeling complexes (ACF complex, etc.) to
achieve the physiological spacing of the chromatin template.
The 5S rDNA nucleosome-positioning sequence flanking the
transcription cassette imposed a constraint for nucleosome
spacing on the cassette, allowing for the assembly of around 3
or 4 nucleosomes. This system responds to the sequential ad-
dition of Gal4-VP16, p300, and acetyl-CoA to result in tran-
scriptional activation. An interesting feature is the near ab-
sence of transcriptional activity in the absence of acetylation.
The exogenous addition of nucleophosmin into this system
produced a 2.5-fold increase in the transcript levels. The ad-
dition of C-terminal deletions of nucleophosmin did not show
the characteristic enhancement of transcription (Fig. 3C), sug-
gesting the importance of the chaperone activity.
Interestingly, we noticed a dependence on acetylation for
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the enhancement of chromatin transcription by nucleophos-
min. Further probing into this phenomenon revealed that nu-
cleophosmin is acetylated by p300, which is necessary for tran-
scriptional activation. Several nonhistone proteins, particularly
transcription factors, become acetylated. While acetylation
generally produces an enhancement in the DNA-binding abil-
ity for some factors (e.g., p53 [22]), it may also decrease the
affinity for DNA in some cases (YY1 [67] and HMG I/Y [57]).
We have shown in this report that the acetylation of nucleo-
phosmin results in enhanced affinity toward acetylated histones
while demonstrating an increased chaperone activity with un-
acetylated histones compared to the unacetylated nucleophos-
min. This is the first report wherein the acetylation of a histone
chaperone enhances its affinity toward acetylated histones.
Recent reports have demonstrated that transcription from
the chromatin template proceeds through a depletion of the
histones on the promoter region (8, 11, 31). A genome-wide
scan of nucleosome occupancy on the active regulatory regions
in S. cerevisiae revealed a depletion of nucleosomes (39),
though the factor(s) responsible for this depletion is still spec-
ulative. The yeast histone chaperone Asf1 has been demon-
strated to deplete nucleosomes from the active chromatin re-
gion (1, 2). Interestingly, Asf1 interacts with the Bramha
complex, an ATP-dependent chromatin-remodeling system in-
volved in the process of transcriptional activation (44). In a
previous report, NAP1 was also shown to facilitate the removal
of the H2A-H2B dimer from the nucleosome (26). We have
shown transcription activation by nucleophosmin in vivo by the
activation of the p53-dependent reporter expression assay. Pre-
viously published data suggest that NPM1 enhances the p53
stability, which could be one of the causal effects on the ob-
served enhancement in the transactivation by NPM1. We have
established the fact that NPM1 is an activator of chromatin
transcription. The fact that the increased stability of p53 or the
inhibition of phosphorylation in the presence of NPM1 could
cause the transcriptional activation as represented in Fig. 7
cannot be discounted, but the drop in the transactivation below
the basal levels (i.e., in the presence of p53 alone) when co-
transfected with the antisense construct of NPM1 cannot be
explained by the same argument. If increased p53 stability were
the only reason, transactivation in the presence of the NPM1
antisense construct would be the same as that of p53 alone. We
therefore hypothesize that NPM1 may act as an important
coactivator in p53-mediated transcriptional activation. In light
of our data and the above presumption, the drop in the trans-
activation by p53 in the absence of NPM1 could be attributed
to the lack of necessary histone chaperone function. However,
in order to establish the global role of NPM1 to induce tran-
scriptional activation, we have also used a different activator-
driven reporter construct (Gal4-VP16 with pG10luc) (Fig. 7C).
In agreement with our hypothesis, the results show a robust
increase in the transactivation potential in the presence of
NPM1. The cotransfection with the NPM1 antisense construct
did not alter the reporter gene expression. Presumably, this
occurs due to the presence of yet-unidentified factors that
could replace the necessity of NPM1 for Gal4-VP16. Taken
together, these data suggest that NPM1 indeed has a global
role to play in the activation of transcription from a chromatin
template in vivo.
Involvement of a histone chaperone in the activation of
chromatin transcription, and which is regulated by acetylation,
provides insight into the possible mechanism of action. It was
demonstrated earlier that the recruitment of p300 by the acti-
vator brings about the promoter-proximal acetylation of the
histones (34, 55, 59). In the event of the recruitment and
subsequent acetylation of the histone chaperone nucleophos-
min, histone removal over the promoter region may be facili-
tated due to the increased affinity among the modified proteins
(nucleophosmin and histones), resulting in enhanced tran-
scription. The necessity of histone chaperone activity in this
process points to the fact that nucleophosmin does not act
merely as a histone sink but may be actively involved in the
process of histone depletion. These observations regarding the
acetylation-dependent transcriptional activation by a histone
chaperone experimentally establish histone chaperones as
unique chromatin-remodeling machinery, which may play a
significant role in the removal of nucleosomal histones in a
replication-independent manner. By employing histone chap-
erones, cellular machineries may help in the replacement of
the active chromatin-specific histone variant (H3.3 [43]) and/or
remove methylated histones to regulate chromatin transcrip-
tion.
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